Kaposi's sarcoma in HIV-infected patients in the era of new antiretrovirals.
Kaposi's sarcoma in HIV-infected patients in the era of new antiretrovirals.
A. Facciolà,E. Rullo,9 Authors,G. Pellicanò
2017 · DOI: 10.26355/eurrev_201712_14036
European Review for Medical and Pharmacological Sciences · 47 Citations
TLDR
HAART represents the first treatment in patients with moderate lesions limited to skin, and it can be sufficient to reduce significantly the size of lesions and, often, the complete disappear in 35% of cases after 3-9 months of treatment.
